An inhibitor of proteasome beta 2 sites sensitizes myeloma cells to immunoproteasome inhibitors

Author(s):: Downey-Kopyscinski, S.; Daily, E.W.; Gautier, M.; Bhatt, A.; Florea, B.I. (0000-0001-7114-2266); Mitsiades, C.S.; Richardson, P.G.; Driessen, C.; Overkleeft, H.S. (0000-0001-6992-4760); Kisselev, A.F.

Published: 2018
Publication type: Article / Letter to editor

Date issued: 2018-10-09
Language: English
Is part of: Blood Advances (2018), Vol. 2, no. 19, p. 2443-2451
hdl: 1887/67598
doi: 10.1182/bloodadvances.2018016360
URL: http://www.bloodadvances.org/content/2/19/2443?sso-checked=true